{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:49:58Z","timestamp":1791668998231,"version":"4.3.4"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.13014","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T11:32:43Z","timestamp":1653046363000},"page":"e2213014","source":"Crossref","is-referenced-by-count":129,"title":["Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder"],"prefix":"10.1001","volume":"5","author":[{"given":"Augustin G. L.","family":"Vannier","sequence":"first","affiliation":[{"name":"Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E. S.","family":"Shay","sequence":"additional","affiliation":[{"name":"Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Fomin","sequence":"additional","affiliation":[{"name":"Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj J.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Texas at Southwestern, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperance","family":"Schaefer","sequence":"additional","affiliation":[{"name":"Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell P.","family":"Goodman","sequence":"additional","affiliation":[{"name":"Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Luther","sequence":"additional","affiliation":[{"name":"Alcohol Liver Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"issue":"1","key":"zoi220386r1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","article-title":"Global burden of alcoholic liver diseases.","volume":"59","author":"Rehm","year":"2013","journal-title":"J Hepatol"},{"issue":"1","key":"zoi220386r2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.v71.1","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases.","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"zoi220386r3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jceh.2014.02.006","article-title":"Assessment of the Model for End-stage Liver Disease (MELD) score in predicting prognosis of patients with alcoholic hepatitis.","volume":"4","author":"Goyal","year":"2014","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"zoi220386r4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/liv.v40.3","article-title":"Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis.","volume":"40","author":"Deltenre","year":"2020","journal-title":"Liver Int"},{"issue":"7","key":"zoi220386r5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep4.v5.7","article-title":"COVID-19 aftershocks on alcohol-associated liver disease: an early cross-sectional report from the US epicenter.","volume":"5","author":"Rutledge","year":"2021","journal-title":"Hepatol Commun"},{"issue":"6","key":"zoi220386r6","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1002\/hep.v74.6","article-title":"Impact of COVID-19 pandemic on liver transplantation and alcohol-associated liver disease in the USA.","volume":"74","author":"Cholankeril","year":"2021","journal-title":"Hepatology"},{"issue":"5","key":"zoi220386r7","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/hep.v73.5","article-title":"Reducing the global burden of alcohol-associated liver disease: a blueprint for action.","volume":"73","author":"Asrani","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"zoi220386r8","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review.","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"zoi220386r9","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/YCO.0000000000000512","article-title":"Selecting an appropriate alcohol pharmacotherapy: review of recent findings.","volume":"32","author":"Castr\u00e9n","year":"2019","journal-title":"Curr Opin Psychiatry"},{"issue":"18","key":"zoi220386r10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"zoi220386r11","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1111\/add.v116.8","article-title":"Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125?556 patients.","volume":"116","author":"Heikkinen","year":"2021","journal-title":"Addiction"},{"issue":"9","key":"zoi220386r12","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/add.v114.9","article-title":"A meta-analysis of the efficacy of gabapentin for treating alcohol use disorder.","volume":"114","author":"Kranzler","year":"2019","journal-title":"Addiction"},{"issue":"1","key":"zoi220386r13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/ADM.0000000000000443","article-title":"Topiramate pharmacotherapy for alcohol use disorder and other addictions: a narrative review.","volume":"13","author":"Manhapra","year":"2019","journal-title":"J Addict Med"},{"issue":"1","key":"zoi220386r14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00213-014-3652-9","article-title":"A preliminary double-blind, placebo-controlled randomized study of baclofen effects in alcoholic smokers.","volume":"232","author":"Leggio","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"9603","key":"zoi220386r15","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"zoi220386r16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.alcohol.2016.12.005","article-title":"A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic.","volume":"62","author":"Owens","year":"2017","journal-title":"Alcohol"},{"issue":"10","key":"zoi220386r17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/MEG.0000000000000922","article-title":"One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.","volume":"29","author":"Barrault","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"zoi220386r18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1192\/bjp.2018.13","article-title":"Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.","volume":"212","author":"Morley","year":"2018","journal-title":"Br J Psychiatry"},{"key":"zoi220386r19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fpsyt.2018.00474","article-title":"Baclofen for the treatment of alcohol use disorder in patients with liver cirrhosis: 10 years after the first evidence.","volume":"9","author":"Mosoni","year":"2018","journal-title":"Front Psychiatry"},{"issue":"6","key":"zoi220386r20","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/hep.v71.6","article-title":"Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis.","volume":"71","author":"Rogal","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"zoi220386r21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/acer.2019.43.issue-2","article-title":"Gender disparities in alcohol use disorder treatment among privately insured patients with alcohol-associated cirrhosis.","volume":"43","author":"Mellinger","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"zoi220386r22","doi-asserted-by":"publisher","DOI":"10.3390\/jpm6010011","article-title":"The Biobank portal for partners personalized medicine: a query tool for working with consented Biobank samples, genotypes, and phenotypes using i2b2.","volume":"6","author":"Gainer","year":"2016","journal-title":"J Pers Med"},{"issue":"3","key":"zoi220386r23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/MOG.0000000000000627","article-title":"The natural history of alcohol-related liver disease.","volume":"36","author":"Parker","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"zoi220386r24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jsat.2015.01.002","article-title":"Examining the specification validity of the HEDIS quality measures for substance use disorders.","volume":"53","author":"Harris","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"12","key":"zoi220386r25","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3949\/ccjm.86a.18128","article-title":"Gabapentin for alcohol use disorder: a good option, or cause for concern?","volume":"86","author":"Modesto-Lowe","year":"2019","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"zoi220386r26","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1111\/add.v116.11","article-title":"The correlates and extent of prescribing of medications for alcohol relapse prevention in England.","volume":"116","author":"Donoghue","year":"2021","journal-title":"Addiction"},{"key":"zoi220386r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108174","article-title":"Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients.","volume":"214","author":"Rittenberg","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi220386r28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","article-title":"Treatment of alcohol use disorders in patients with alcoholic liver disease.","volume":"65","author":"Addolorato","year":"2016","journal-title":"J Hepatol"},{"issue":"7","key":"zoi220386r29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/add.2004.99.issue-7","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"key":"zoi220386r30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/SART.S9345","article-title":"Safety and efficacy of acamprosate for the treatment of alcohol dependence.","volume":"6","author":"Yahn","year":"2013","journal-title":"Subst Abuse"},{"key":"zoi220386r31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.drugalcdep.2016.06.027","article-title":"National trends in alcohol pharmacotherapy: findings from an Australian claims database.","volume":"166","author":"Morley","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"zoi220386r33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","article-title":"Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial.","volume":"180","author":"Anton","year":"2020","journal-title":"JAMA Intern Med"},{"key":"zoi220386r32","unstructured":"US Food and Drug Administration. VIVITROL (naltrexone for extended-release injectable suspension) label. 2010. Accessed February 24, 2022. https:\/\/www.fda.gov\/medwatch?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792500\/vannier_2022_oi_220386_1652286065.41426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T11:32:47Z","timestamp":1653046367000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.13014","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]}}}